A system comprising: a nasogastric tube comprising: (a) a main lumen having one or more proximal connectors for connecting to a source of substances or pressure; (b) at least four vacuum lumens peripherally surrounding said main lumen; and (c) at least four suction ports for sealingly drawing an inner wall of an esophagus thereagainst, each of said at least four suction ports associated with a different one of said at least four vacuum lumens, wherein said at least four suction ports are distributed between at least two different locations along a longitudinal axis of said nasogastric tube.
|
1. A system comprising: a tube comprising:
(a) a main lumen having one or more proximal connectors for connecting to a source of substances or pressure;
(b) at least six discrete vacuum lumens peripherally surrounding said main lumen;
(c) a first set of at least three suction ports for circumferentially sealingly drawing an inner wall of an esophagus thereagainst, each of said first set of at least three suction ports associated with a different one of said at least six discrete vacuum lumens and peripherally distributed around said main lumen in a same longitudinal location with respect to said main lumen;
(d) a second set of at least three suction ports associated with a different one of said at least six discrete vacuum lumens and peripherally distributed around said main lumen in a same longitudinal location with respect to said main lumen; such that each of said at least six discrete vacuum lumens is associated with a single suction port; wherein said first and second sets of at least three suction ports are spaced apart between at least two different locations along a longitudinal axis of said tube; and
(e) a valve connected to said six discrete vacuum lumens, said valve structured to interchange applied vacuum between (i) those of said six discrete vacuum lumens which are associated with said first set of at least three suction ports and (ii) those of said six discrete vacuum lumens which are associated with said second set of at least three suction ports, thereby changing location of the esophagus coupling to the tube and diminishing or preventing damage to esophageal tissue.
13. A method comprising: introducing a nasogastric tube into an esophagus of a patient, said nasogastric tube comprising (a) a main lumen having one or more proximal connectors for connecting to a source of substances or pressure; (b) at least six discrete vacuum lumens peripherally surrounding said main lumen; and (c) a first set of at least three suction ports for circumferentially sealingly drawing an inner wall of an esophagus thereagainst, each of said at least three suction ports associated with a different one of said at least six discrete vacuum lumens and peripherally distributed around said main lumen in a same longitudinal location with respect to said main lumen, (d) a second set of at least three suction ports associated with a different one of said at least six discrete vacuum lumens and peripherally distributed around said main lumen in a same longitudinal location with respect to said main lumen; such that each of said at least six discrete vacuum lumens is associated with a single suction port; wherein said first and second sets of at least three suction ports are spaced apart between at least two different locations along a longitudinal axis of said nasogastric tube, (e) a valve connected to said at least six discrete vacuum lumens, said valve structured to interchange applied vacuum between (i) those of said at least six discrete vacuum lumens which are associated with said first set of at least three suction ports and (ii) those of said at vacuum lumens which are associated with said second set of at least three suction ports, thereby changing location of esophagus coupling to the nasogastric tube and diminishing or preventing damage to esophageal tissue; and applying a vacuum interchangeably to said at least six vacuum lumens so as to sealingly draw an inner wall of an esophagus thereagainst, each time in a different location along said esophagus.
2. The system according to
3. The system of
4. The system of
6. The system of
7. The system of
8. The system of
9. The system of
10. The system of
11. The system of
12. The system of 1, wherein said two or more longitudinal radiopaque stripes are embedded in an outer wall of said tube.
14. The method of
15. The method of
16. The method of
17. The method of
18. The method of
19. The method of
20. The method of
|
This application is a continuation in part of U.S. application Ser. No. 13/982,289, filed Jul. 29, 2013, which is a National Stage of International Application No. PCT/US2012/046850, filed Jul. 16, 2012, which claims priority to and the benefit of U.S. Provisional Application No. 61/508,670, filed Jul. 17, 2011. The entire contents of all of these are incorporated herein by reference.
The present invention relates generally to nasogastric tubes.
Enteral feeding is a form of hyperalimentation and metabolic support in which nutrient formulas or medicaments are delivered directly to the GI tract, either to the stomach or the duodenum. A nasogastric tube (NGT) is used for feeding and administering drugs and other oral agents. The tube is inserted into the patient's esophagus and stomach in order to ensure the passage of the agents into the stomach and not into the lungs. The NGT can also be used for suction of fluids from the stomach.
However, the use of NGTs can have disadvantages. Minor complications include nose bleeds, sinusitis, and a sore throat. Sometimes more significant complications occur including erosion of the nose where the tube is anchored, esophageal perforation, pulmonary aspiration, a collapsed lung, or intracranial placement of the tube.
Even worse, during feeding, excessive gastric pressure may result. From time to time, the body relieves such excess gastric pressure by expelling gas or liquid or reflux fluid. The fluids are expelled from the stomach through the esophagus to the mouth or nasal pathways. The reflux fluids may be inhaled into the lungs with possible risk of aspiration pneumonia, bacterial infection in the pharynx or esophagus or any other ailments. Accordingly, numerous studies have linked the use of the NGT to an increase in ventilator-associated pneumonia (VAP). VAP is the most common nosocomial infection in the intensive care unit (ICU), and it is associated with prolonged hospitalization, increased health care costs, and high attributable mortality.
There thus exists a pressing need for an NGT that is capable of significantly reducing the risk of reflux food and developing VAP.
The following embodiments and aspects thereof are described and illustrated in conjunction with systems, tools and methods which are meant to be exemplary and illustrative, not limiting in scope.
There is provided, in accordance with an embodiment, a system comprising: a nasogastric tube comprising: (a) a main lumen having one or more proximal connectors for connecting to a source of substances or pressure; (b) at least four vacuum lumens peripherally surrounding said main lumen; and (c) at least four suction ports for sealingly drawing an inner wall of an esophagus thereagainst, each of said at least four suction ports associated with a different one of said at least four vacuum lumens, wherein said at least four suction ports are distributed between at least two different locations along a longitudinal axis of said nasogastric tube.
There is further provided, in accordance with an embodiment, a method comprising: introducing a nasogastric tube into an esophagus of a patient, said nasogastric tube comprising a main lumen having one or more proximal connectors for connecting to a source of substances or pressure, four or more vacuum lumens peripheral to said main lumen, and four or more suction ports, each of said four or more suction ports associated with a different one of said four or more vacuum lumens, wherein said four or more suction ports are distributed between at least two different locations along said nasogastric tube; and applying vacuum interchangeably to said four or more vacuum lumens so as to sealingly draw an inner wall of an esophagus thereagainst, each time in a different location along said esophagus.
In some embodiments, the system further comprises a vacuum source connected to said at least four vacuum lumens.
In some embodiments, said at least four vacuum lumens are connected to said vacuum source via a pressure regulator and a valve.
In some embodiments, said main lumen and said at least four vacuum lumens are constructed as one unit.
In some embodiments, said at least four vacuum lumens are a separate unit from said main lumen, and wherein said at least four vacuum lumens are slidable relative to said main lumen.
In some embodiments, said main lumen and said at least four vacuum lumens are arranged as concentrically arranged conduits.
In some embodiments, the system further comprises one or more auxiliary suction ports proximal to said at least four suction ports.
In some embodiments, each of said at least four suction ports comprises a graduated edging.
In some embodiments, the system further comprises a manifold configured to connect said at least four vacuum lumens to said valve.
In some embodiments, said manifold is transparent.
In some embodiments, said at least four vacuum lumens comprise at least six vacuum lumens.
In some embodiments, at least one of said at least four suction ports comprises two or more suction ports, successively arranged along a portion of a longitudinal axis of said nasogastric tube.
In some embodiments, said nasogastric tube further comprises two or more longitudinal radiopaque stripes.
In some embodiments, said two or more longitudinal radiopaque stripes are embedded in an outer wall of said nasogastric tube.
In some embodiments, the method further comprises regulating the vacuum so that a suction level is not constant over time.
In some embodiments, the method further comprises regulating vacuum to said four or more suction ports of said four or more vacuum lumen, so as to create peristaltic movement or other oscillatory movement of the esophagus.
In some embodiments, said applying of the vacuum restricts at least 60% of passage through the esophagus.
In some embodiments, the method further comprises visually monitoring a transparent manifold coupling said four or more vacuum lumens with said valve for backflow of gastric substances.
In addition to the exemplary aspects and embodiments described above, further aspects and embodiments will become apparent by reference to the figures and by study of the following detailed description.
The present invention will be understood and appreciated more fully from the following detailed description taken in conjunction with the drawings in which:
The present invention provides a nasogastric tube (NGT) and a method thereof, as is described more in detail hereinbelow. The NGT includes a tube and a vacuum control unit. The vacuum control unit couples the esophagus to the tube thus disabling the reflux of the food along the esophagus to the trachea. Furthermore, the structure of an NGT according to the present invention enables locally selective application of the vacuum within the esophagus. Thus, the location of the esophagus coupling to the tube may be changed in time in order to diminish tissue damage to the esophagus. An NGT according to the present invention can be used in ICU, or elsewhere, in order to reduce the complications associated with reflux such as the risk of VAP and in order to prevent or reduce tissue damage.
According to the present invention, the inner wall of the esophagus is drawn by negative pressure (vacuum) towards and against the outer contour of the NGT. A vacuum control unit, which is connected to the hospital vacuum unit or any other vacuum unit, enables either simultaneous vacuum pressure in one or more suction units of the NGT or changeable vacuum pressure between the different suction units. In this way, the NGT of the present invention prevents reflux and aspiration of substances or liquids into the patient's lungs and prevents tissue damage, while obviating the need to remove and replace the entire device from the patient's esophagus.
In some embodiments, a tube according to the present invention may be used in other locations in the GI tract or in any other body lumen, such as arteries, veins, etc. However, for simplicity of discussion, this tube is referred to throughout the specification as an NGT.
Reference is now made to
NGT 10 includes a main (typically, but not necessarily, central) lumen 12. Main lumen 12 may be used to feed and administer drugs and other oral agents, and may also be used for sucking fluids from the stomach. As such, as is known in the art, main lumen 12 may be a double lumen, one lumen for feeding and the other lumen for suction (not to be confused with the vacuum lumens mentioned later). Main lumen 12 is provided with one or more suitable proximal connectors 14 for connecting to a source of substances for feeding or administering, and optionally to a source of pressure (e.g., suction), as is known in the art.
NGT 10 includes one or more vacuum lumens 16 that peripherally surround main lumen 12. The term “peripherally surround” as used in the description and claims, encompasses continuous surrounding (no gaps between the vacuum lumens or one continuous, peripheral vacuum lumen) and discontinuous surrounding (wherein there are separations between discrete vacuum lumens). In one embodiment, illustrated in
Main lumen 12 may be constructed from any suitable biocompatible material, such as but not limited to, polyurethane, silicone, polyvinyl chloride and many others. The vacuum lumens 16 may be constructed of similar materials, but alternatively may be constructed of medically safe metals, such as but not limited to, stainless steel, titanium alloys, NITINOL and others. Generally, without limitation, main lumen 12 may have a length in the range of 50 to 130 cm, with an outside diameter in the range of 5-12 Fr.
Main lumen 12 and vacuum lumens 16 may be constructed as one unit. Alternatively, vacuum lumens 16 may be a separate unit which is slid over main lumen 12, as illustrated in
With reference to
Pressure regulator 20 may be used to reduce or otherwise regulate the negative pressure generated by vacuum source 18. For example, pressure regulator 20 may be used to match the vacuum level generated by vacuum source 18 to the vacuum level needed in vacuum sealing portion 24. Such vacuum pressure may be, for example, between 0.5-50, 50-100, 100-200, 200-300, 300-400, 400-500, 500-600 or 600-700 mmHg. Different vacuum pressure values may be suitable to different patients and/or to different luminal structures into which the tube of the present invention is inserted.
Valve 22 may be used to shift the vacuum between the different vacuum lumens 16 so that the suction level is not constant over time in the vacuum sealing portion 24, which may provide variability in how the esophagus wall is sucked in, and for how long.
NGT 10 may be provided with different numbers of vacuum sealing portions 24 and suction ports 26, and the vacuum to the sealing portions 24 may be regulated so as to create peristaltic movement or other oscillatory movement of the esophagus.
In accordance with an embodiment of the invention, one or more auxiliary suction ports 33 are provided proximal to vacuum sealing portion 24. Since vacuum sealing portion 24 seals off the esophagus, any oropharyngeal secretions, such as saliva, may accumulate above (i.e., proximal to) vacuum sealing portion 24. Auxiliary suction ports 33 may be used to suck and remove such secretions. Additionally or alternatively, one or more of vacuum lumens 16 may be used to evacuate liquids arriving from the patient's stomach. That is, if a reflux occurs, one or more of vacuum lumens 16 may withdrawn at least a portion of it, through suction ports 26, towards valve 22. There, the stomach contents may be collected inside a suitable reservoir and then discarded.
Vacuum source 18 is preferably activated following the insertion and localization of NGT 10 in the esophagus in order to reduce the risk of VAP, or other bacterial infections, by preventing or minimizing reflux food and liquid aspiration into the lungs.
Reference is now made to
A main tube 102 may extend between the patient and the food and/or medicament supply. Main tube 102 may include, at manifold 100, two or more junctions 104 and 106. Junctions 104 and 106 may be used for alternating between different vacuum lumens or groups of vacuum lumens. That is, each of junctions 104 and 106 may interconnect different vacuum lumens or groups of vacuum lumens to the vacuum source. Junction 104, for example, may be connected to the vacuum source via a first tube (represented by tube portions 108 and 110). Junction 106, for example, may be connected to the vacuum source via a second tube (represented by tube portions 112 and 114). Tube portions 110 and 114 may be connected to the vacuum source through a selector 100. Selector 106 may have two possible states: In the first state, negative pressure from the vacuum source is channeled towards portion 110 and from there to junction 104. In the second state, negative pressure from the vacuum source is channeled towards portion 114 and from there to junction 106. In embodiments where more than two junctions are present (not shown), a selector may have a number of states corresponding to the number of junctions.
Optionally, manifold 100 may include one or more vacuum discharge ports, for releasing negative pressure from a certain vacuum lumen or a group of vacuum lumens after the negative pressure has been switched away from this lumen or group of vacuum lumens by selector 116. Two exemplary vacuum discharge ports 118 and 120 are shown in the figure. Optionally, the vacuum discharge ports 118 and 120 may each be a cap threadable at some point between selector 116 and junctions 104 and 106, respectively. After the caregiver has switched the vacuum from a first vacuum lumen (or a first group of lumens) to a second vacuum lumen (or a second group of lumens), he or she may use the suitable one of vacuum discharge ports 118 and 120 in order to immediately discharge the negative pressure from the first vacuum lumen (or the first group of lumens). This way, the inner wall of the esophagus, at the vacuum port(s) connected to the first vacuum lumen (or the first group of lumens), may be immediately released from the vacuum port(s) and tissue damage may be prevented or at least mitigated.
One method of using NGT 10 of the present invention includes the following steps, without limitation and not necessarily in sequential order:
Reference is now made to
Each vacuum lumen 16 includes a suction port 26, specifically denoted 26a, 26b, 26c, 26d, 26e and 26f correspondingly. Therefore, each of suction ports 26 is associated with one of lumens 16. Suction ports 26a, 26b, 26c, 26d, 26e and 26f are distributed along a longitudinal axis of nasogastric tube 50. Suction ports 26a, 26c and 26e are located above suction ports 26b, 26d and 26f along the longitudinal axis of nasogastric tube 50 and with respect to a patient's body. Such a longitudinal axis may be advantageously located within main lumen 12.
With specific reference to
Therefore, for example, applying vacuum to vacuum lumens 16a or 16c or 16e or to any combination thereof, allows sealing of the esophagus against nasogastric tube 50 in different peripheral locations (i.e., depending on the vacuum lumens which are used) and in different levels (i.e., depending on how many vacuum lumen are used) but in a specific longitudinal location (denoted by line I-I with respect to nasogastric tube 50 in
Hence, the location of the vacuum lumens within the nasogastric tube according to the present invention determines the peripheral location of the applied vacuum and the location of the suction ports determines the longitudinal location of the applied vacuum within the esophagus. It should be noted that the positioning of nasogastric tube 50 within the esophagus as performed by the attending caregiver should be also considered. Switching the applied vacuum between the vacuum lumens allows applying vacuum on the esophagus inner wall at different locations peripherally and longitudinally during time, thus diminishing or preventing damage to the esophagus tissue facing the suction ports.
Valve 22 may be used to switch the vacuum between one or more vacuum lumens 16. Valve 22 may be separately connected to each vacuum lumen 16 or, for example, connected to all of vacuum lumens 16 having suction ports 26 at the same longitudinal location with respect to nasogastric tube 50 together. Obviously, the latter setup of valve 22 allows less freedom in switching between vacuum lumens 16. Hence, valve 22 may be used to switch the applied vacuum after a time duration from one or more vacuum lumens located at specific peripheral and longitudinal locations to one or more vacuum lumens located at other peripheral locations or furthermore at other longitudinal locations. Such a switch may be preformed gradually in order to keep the esophagus sealed at least to some extent against nasogastric tube 50 during the switch.
Nasogastric tube 50 may include two or more vacuum lumens 16 which peripherally surround main lumen 12. At least two of vacuum ports 26 are located at different longitudinal locations along nasogastric tube 50 in order to allow a longitudinal location switch within the esophagus.
Suction ports 26 are elliptical but may be of any other form, such as circular. Suction ports 26 may include a graduated edging 28 to prevent or diminish damage to the esophagus tissue while an inner wall of the esophagus is pressed against suction ports 26. Graduated edging 28 is advantageously graduated in an obtuse angle. Graduated edging 28 may be graduated entirely or only include a graduated portion. Generally, graduated edging 28 may provide each of suction ports 26 with a concave shape, having an opening approximately in its middle.
Nasogastric tube 50 may be coupled with a manifold (not shown). The manifold may connect vacuum lumens 16 to valve 22 in a separate manner to allow vacuum application to one or more vacuum lumens 16. The manifold may be transparent in order to visually monitor backflow of gastric substances, such as bile.
In some embodiments, at least one suction port 26 may include two or more suction ports, successively arranged along a portion of a longitudinal axis of nasogastric tube 50.
A method of using NGT 50 of the present invention may include the following steps, without limitation and not necessarily in sequential order:
The vacuum may be applied to one or more vacuum lumens each time, and in each time to vacuum lumens which include suction ports peripherally distributed around the same location along a longitudinal axis of the NGT (for example, vacuum lumens 16a and 16c or vacuum lumens 16b, 16 d and 16f of
The interchanging between the vacuum lumens to which a vacuum is applied may be performed at various manners, for example, it may be performed once or more per patient while each location change may be performed once in a constant or variable period of time, all according to the caregiver discretion regarding the specific patient.
The method may further include the step of regulating the vacuum so that a suction level is not constant over time in the suction ports. The vacuum may be regulated to the vacuum ports so as to create peristaltic movement or other oscillatory movement of the esophagus.
In some embodiments, the vacuum may be applied such that to restricts at least 60% of passage through the esophagus.
The method may further include the step of visually monitoring a transparent manifold which couples the vacuum lumens with a valve for backflow of gastric substances, such as bile.
In some embodiments of the present invention, the present invention may be utilized to insert one or more probes through main lumen 12, through one or more of vacuum lumens 16 and/or through a different, dedicated lumen (not shown) into the patient's body. Such probes may include, for example: a temperature sensor, an electromagnetic radiation sensor, a pH sensor, an image sensor, a fiber optic, an ultrasound probe, an OCT (optical coherence tomography) probe, a mini MRI (magnetic resonance imaging) probe, etc.
Reference is now made to
Tube 200 may include one or more radiopaque stripes, such as stripes 202-212, disposed along the longitudinal axis of the tube. Radiopaque stripes 202-212 may be visible, when tube 200 (or a portion thereof) is inside the patient, using X-ray imaging and/or other types of electromagnetic radiation imaging. That is, radiopaque stripes 202-212 are made of a radiodense material which inhibits the passage of some or all electromagnetic radiation, thereby creating a contrast in relation to more radiolucent body tissue and/or radiolucent portions of a medical device. Generally, if two or more parallel, longitudinal radiopaque stripes are present, the resulting electromagnetic radiation image may enable a better depth perception of the tube. This, since one or more of the stripes may be farther away from the imager than other one or more of the stripes. Furthermore, having two or more parallel, longitudinal radiopaque stripes may enable visualizing a situation in which the tube is twisted; this will result in a spiral-like image of the stripes.
An example of a suitable radiodense material is Barium sulfate, but those of skill in the art will recognize that other known radiodense materials may be used. In case Barium sulfate is used, its density in stripes 202-212 may be, for example, between 40-60%, between 60-80% or higher. The remainder percentage may be one or more filler materials.
Stripes 202-212, whether by virtue of their high-percentage Barium sulfate contents and/or their thickness, may endow tube 200 with a certain rigidity. This rigidity is to a degree which assists the caregiver in pushing the tube down the GI tract (or any other bodily lumen) on one hand, but still allows the tube to resiliently maneuver through the pertinent bodily lumen.
Optionally, one or more of stripes 202-212 may have an essentially triangular cross section, as shown in the figure. One apex of the triangle may be directed towards the inside of tube, and the base opposite to that apex may be directed towards the outside of the tube. In other embodiments (not shown), one or more of the stripes may have a rectangular cross-section, a circular cross-section, or an otherwise shaped cross-section.
Stripes 202-212 are optionally embedded, at least partially, in the outer wall of tube 200. Further optionally, stripes 202-212 may slightly protrude beyond the outside surface of the tube. For example, the protrusion may be by 50-100 micrometers, 100-150 micrometers, 150-250 micrometers, 250-400 micrometers or more. This protrusion may enable the caregiver holding tube 200 to get a better grip of the tube, especially when the tube has to be rotated. The protrusion may prevent the tube from slipping in the caregiver's hands while rotated.
It will be appreciated by persons skilled in the art that the present invention is not limited by what has been particularly shown and described hereinabove. Rather the scope of the present invention includes both combinations and subcombinations of the features described hereinabove as well as modifications and variations thereof which would occur to a person of skill in the art upon reading the foregoing description and which are not in the prior art.
Haytman, Eyal, Besser, Doron, Ben Ezra, Guy, Shaked, Orit, Nevler, Avinoam
Patent | Priority | Assignee | Title |
10350145, | Jul 17 2011 | ENVIZION MEDICAL LTD | Nasogastric tube |
10646406, | Jul 17 2011 | ENVIZION MEDICAL LTD | Nasogastric tube |
11730926, | Aug 31 2020 | Avent, Inc | System and method for detecting medical device location and orientation in relation to patient anatomy |
ER9839, |
Patent | Priority | Assignee | Title |
5389074, | Oct 27 1993 | The Regents of the University of California | Body insertion tube with anesthetic jacket |
5707351, | Jun 06 1995 | DAVOL, INC | Remote tubing assembly |
6695764, | Aug 13 1999 | Boston Scientific Scimed, Inc | Apparatus for treating wall of body cavity |
6790214, | May 17 2002 | ENDOGASTRIC SOLUTIONS, INC | Transoral endoscopic gastroesophageal flap valve restoration device, assembly, system and method |
7794425, | Dec 21 2006 | CITIBANK, N A | Gastro-esophageal reflux control system and pump |
7967780, | Aug 29 2007 | CITIBANK, N A | Gastro-esophageal reflux control system and pump |
8100874, | May 22 2009 | SUMMIT MEDICAL, LLC | Tissue refining device |
20030208209, | |||
20040153098, | |||
20040220515, | |||
20050059962, | |||
20090306626, | |||
20110046653, | |||
20130310806, | |||
20150174013, | |||
EP2301512, | |||
WO3034976, | |||
WO2015198297, | |||
WO2016024260, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Dec 05 2013 | NUTRISEAL LIMITED PARTNERSHIP | (assignment on the face of the patent) | / | |||
Jun 11 2014 | HAYTMAN, EYAL | TURBO SEAL L P | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 033317 | /0194 | |
Jun 16 2014 | BEN EZRA, GUY | TURBO SEAL L P | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 033317 | /0194 | |
Jun 16 2014 | NEVLER, AVINOAM | TURBO SEAL L P | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 033317 | /0194 | |
Jun 16 2014 | SHAKED, ORIT | TURBO SEAL L P | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 033317 | /0194 | |
Jun 16 2014 | BESSER, DORON | TURBO SEAL L P | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 033317 | /0194 | |
Dec 25 2014 | TURBOSEAL LIMITED PARTNERSHIP | NUTRISEAL LIMITED PARTNERSHIP | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 042704 | /0475 | |
Jul 12 2018 | NUTRISEAL L P | ENVIZION MEDICAL LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 046344 | /0440 | |
Sep 19 2023 | ENVIZION MEDICAL LTD | ALPHA CAPITAL ANSTALT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 064961 | /0581 | |
Nov 01 2023 | ENVIZION MEDICAL LTD | ALPHA CAPITAL ANSTALT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 065486 | /0113 |
Date | Maintenance Fee Events |
Mar 26 2021 | M2551: Payment of Maintenance Fee, 4th Yr, Small Entity. |
Date | Maintenance Schedule |
Oct 17 2020 | 4 years fee payment window open |
Apr 17 2021 | 6 months grace period start (w surcharge) |
Oct 17 2021 | patent expiry (for year 4) |
Oct 17 2023 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 17 2024 | 8 years fee payment window open |
Apr 17 2025 | 6 months grace period start (w surcharge) |
Oct 17 2025 | patent expiry (for year 8) |
Oct 17 2027 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 17 2028 | 12 years fee payment window open |
Apr 17 2029 | 6 months grace period start (w surcharge) |
Oct 17 2029 | patent expiry (for year 12) |
Oct 17 2031 | 2 years to revive unintentionally abandoned end. (for year 12) |